Literature DB >> 19017485

SIRT1: roles in aging and cancer.

Eun-Joo Kim1, Soo-Jong Um.   

Abstract

Aging and cancer both occur as a result of accumulated cellular damage, and both are related to the regulation of specific genes in the damage response. Recent research has unveiled connections between the mechanisms of aging and cancer, but how to prevent the development of cancer and increase longevity remain unknown. SIRT1 (the mammalian Sir2), which has NAD(+)-dependent class III histone deacetylase activity, may be a key gene linking the modulation of cancer and aging. SIRT1 has broad biological functions in growth regulation, stress response, tumorigenesis, endocrine signaling, and extended lifespan. Here, we focus on the current knowledge regarding the role of SIRT1 in aging and cancer, and discuss the implications of SIRT1 as a therapeutic target for the optimal balance between anti-aging and anti-cancer activities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19017485     DOI: 10.5483/bmbrep.2008.41.11.751

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  34 in total

1.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

2.  HDAC3 is negatively regulated by the nuclear protein DBC1.

Authors:  Claudia C S Chini; Carlos Escande; Veronica Nin; Eduardo N Chini
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

3.  Histone/protein deacetylase SIRT1 is an anticancer therapeutic target.

Authors:  Bor-Jang Hwang; Amrita Madabushi; Jin Jin; Shiou-Yuh S Lin; A-Lien Lu
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

4.  NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity.

Authors:  Sathisha Upparahalli Venkateshaiah; Sharmin Khan; Wen Ling; Rakesh Bam; Xin Li; Frits van Rhee; Saad Usmani; Bart Barlogie; Joshua Epstein; Shmuel Yaccoby
Journal:  Exp Hematol       Date:  2013-02-19       Impact factor: 3.084

Review 5.  Structural basis for sirtuin activity and inhibition.

Authors:  Hua Yuan; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

6.  SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis.

Authors:  V Byles; L Zhu; J D Lovaas; L K Chmilewski; J Wang; D V Faller; Y Dai
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

Review 7.  Gene activation regresses atherosclerosis, promotes health, and enhances longevity.

Authors:  Pauli V Luoma
Journal:  Lipids Health Dis       Date:  2010-07-06       Impact factor: 3.876

8.  HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress.

Authors:  Clémence Coudre; Julien Alani; William Ritchie; Véronique Marsaud; Brigitte Sola; Julie Cahu
Journal:  Cell Cycle       Date:  2016-06-24       Impact factor: 4.534

Review 9.  Structural basis for sirtuin function: what we know and what we don't.

Authors:  Brandi D Sanders; Brittany Jackson; Ronen Marmorstein
Journal:  Biochim Biophys Acta       Date:  2009-09-18

Review 10.  Healthy clocks, healthy body, healthy mind.

Authors:  Akhilesh B Reddy; John S O'Neill
Journal:  Trends Cell Biol       Date:  2009-11-16       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.